Use your browser's back button to choose another title or click here for a New Search.

How to Get the Presentation

 Open slides (pptx)




Bookmark and Share

Hepatitis C Awareness and Risky Injection Behaviors Among Injection Drug Users in Treatment.

Presented at the Addiction Health Services Research Conference, Lexington, Kentucky, October 25-27, 2010

P. Todd Korthius, MD, MPH (Oregon Health & Science University, WS Node), Daniel J. Feaster, PhD (University of Miami Miller School of Medicine, FNA Node), Zoilyn L. Gomez (University of Miami Miller School of Medicine, FNA Node), Moupali Das, MD, MPH (San Francisco Department of Public Health, WS Node), Susan Tross, PhD (New York State Psychiatric Hospital, GNY Node), Katharina Wiest, PhD (CODA, Inc., WS Node), Antoine B. Douaihy, MD (Western Psychiatric Institute and Clinic, ATS Node), Raul N. Mandler, MD (Center for the Clinical Trials Network, NIDA), James L. Sorensen, PhD (San Francisco General Hospital, UCSF, WS Node), Grant N. Colfax, MD (San Francisco Department of Public Health, WS Node), Patricia E. Penn, PhD (La Frontera Center, Inc., WS Node), Diane Lape (CODA, Inc., WS Node), Lisa R. Metsch, PhD (University of Miami Miller School of Medicine, FNA Node).

HIV testing is changing, as new technology allows testing with results in 20 minutes and studies show much transmission is by people unaware they have HIV. The CDC now recommends more testing and less counseling at the time of testing. This presentation served as an introduction to a session at the conference focused on a multicenter study being conducted in the National Drug Abuse Treatment Clinical Trials Network (CTN), protocol CTN-0032. The aim of 0032 is to evaluate a more effective HIV testing strategy designed to increase receipt of HIV test results and decrease HIV sexual risk behaviors. Study participants were 1281 drug treatment clients enrolled at 12 community treatment programs who reported not being HIV positive and not recently receiving test results. Sites launched in early 2009 and outcomes are pending. This session will address participants' baseline HIV and HCV status and testing history, levels of hepatitis C awareness and risky injection behaviors, and how one community treatment program integrated HIV testing into routine clinic services. (Presentation, PowerPoint slides, English, 2010)

Keywords: Adoption of interventions | Community health services | Condom use | Hepatitis C | Injection drug use | Sexual risk behavior | Sexually transmitted diseases | Addiction Health Services Research Conference, 2010

Document No: 545

Submitted by Todd Korthuis, MD, MPH, Oregon Health & Science University, WS Node, 11/12/2010.



Colfax, Grant N. mail
Das, Moupali mail
Douaihy, Antoine B. mail
Feaster, Daniel J. mail
Gomez, Zoilyn L.
Korthuis, P. Todd mail
Lape, Diane
Mandler, Raul N. mail
Metsch, Lisa R. mail
Penn, Patricia E. mail
Sorensen, James L. mail
Tross, Susan mail
Wiest, Katharina mail
NIDA-CTN-0032 www
Florda Node Alliance search www
Appalachian Tri-State search www
Mid-Atlantic search www
New England Consortium search www
Ohio Valley search www
Southern Consortium search www
Southwest search www
Western States search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 11/2010 --